Exacerbation Profile and Risk Factors in a Type-2–Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes

医学 恶化 呼出气一氧化氮 哮喘 哮喘恶化 嗜酸性粒细胞 内科学 免疫学 队列 肺活量测定
作者
P. Jane McDowell,John Busby,Catherine E. Hanratty,Ratko Djukanović,Ashley Woodcock,Samantha Walker,Timothy C. Hardman,Joseph R. Arron,David F. Choy,Peter Bradding,Christopher Brightling,Rekha Chaudhuri,Douglas C. Cowan,Adel Mansur,Stephen J. Fowler,Sarah Diver,Peter Howarth,James Lordan,Andrew Menzies‐Gow,Timothy Harrison,Douglas S. Robinson,Cécile Holweg,John G. Matthews,Ian D. Pavord,Liam G. Heaney
出处
期刊:American Journal of Respiratory and Critical Care Medicine [American Thoracic Society]
卷期号:206 (5): 545-553 被引量:24
标识
DOI:10.1164/rccm.202201-0129oc
摘要

Rationale: The past 25 years have seen huge progress in understanding of the pathobiology of type-2 (T2) asthma, identification of measurable biomarkers, and the emergence of novel monoclonal antibody treatments. Although present in a minority of patients with severe asthma, very little is known about the mechanisms underlying T2-low asthma, making it a significant unmet need in asthma research. Objectives: The objective of this study was to explore the differences between study exacerbators and nonexacerbators, to describe physiological changes at exacerbation in those who are T2HIGH and T2LOW at the time of exacerbation, and to evaluate the stability of inflammatory phenotypes when stable and at exacerbation. Methods: Exacerbation assessment was a prespecified secondary analysis of data from a 48-week, multicenter, randomized controlled clinical study comparing the use of biomarkers and symptoms to adjust steroid treatment in a T2-low severe asthma–enriched cohort. Participants were phenotyped as T2LOW (fractional exhaled nitric oxide ⩽ 20 ppb and blood eosinophil count ⩽ 150 cells/µl) or T2HIGH (fractional exhaled nitric oxide > 20 or blood eosinophil count > 150) at study enrollment and at each exacerbation. Here, we report the findings of the exacerbation analyses, including comparison of exacerbators and nonexacerbators, the physiological changes at exacerbation in those who had evidence of T2 biology at exacerbation versus those that did not, and the stability of inflammatory phenotypes when stable and at exacerbation. Measurements and Main Results: Of the 301 participants, 60.8% (183) had one or more self-reported exacerbations (total of 390). Exacerbators were more likely to be female, have a higher body mass index, and have more exacerbations requiring oral corticosteroid and unscheduled primary care attendances for exacerbations. At enrollment, 23.6% (71) were T2LOW and 76.4% (230) T2HIGH. The T2LOW group had more asthma primary care attendances, were more likely to have a previous admission to HDU (high dependency unit)/ICU and to be receiving maintenance oral corticosteroids. At exacerbation, the T2LOW events were indistinguishable from T2HIGH exacerbations in terms of lung function (mean fall in T2LOW FEV1, 200 [400] ml vs. T2HIGH 200 [300] ml; P = 0.93) and symptom increase (ACQ5: T2LOW, 1.4 [0.8] vs. T2HIGH, 1.3 [0.8]; P = 0.72), with no increase in T2 biomarkers from stable to exacerbation state in the T2LOW exacerbations. The inflammatory phenotype within individual patients was dynamic; inflammatory phenotype at study entry did not have a significant association with exacerbation phenotype. Conclusions: Asthma exacerbations demonstrating a T2LOW phenotype were physiologically and symptomatically similar to T2HIGH exacerbations. T2LOW asthma was an unstable phenotype, suggesting that exacerbation phenotyping should occur at the time of exacerbation. The clinically significant exacerbations in participants without evidence of T2 biology at the time of exacerbation highlight the unmet and pressing need to further understand the mechanisms at play in non-T2 asthma. Clinical trial registered with www.clinicaltrials.gov (NCT02717689).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
爱学习的小李完成签到 ,获得积分10
刚刚
若水完成签到 ,获得积分10
刚刚
SYLH应助tian采纳,获得10
刚刚
脑洞疼应助tian采纳,获得10
1秒前
Ava应助tian采纳,获得10
1秒前
领导范儿应助tian采纳,获得10
1秒前
桐桐应助tian采纳,获得10
1秒前
乐乐应助tian采纳,获得10
1秒前
乐乐应助tian采纳,获得10
1秒前
wbscz应助tian采纳,获得10
1秒前
ding应助tian采纳,获得10
1秒前
1秒前
研友_LBRPOL完成签到,获得积分10
3秒前
gao完成签到 ,获得积分10
4秒前
zq发布了新的文献求助10
4秒前
韭黄发布了新的文献求助10
5秒前
她的城完成签到,获得积分0
5秒前
单薄的钢笔完成签到,获得积分10
7秒前
568923完成签到,获得积分10
9秒前
Grace159完成签到 ,获得积分10
12秒前
咖啡博士发布了新的文献求助10
14秒前
彦祖i学术完成签到,获得积分10
16秒前
zq完成签到,获得积分20
17秒前
HY完成签到,获得积分10
18秒前
不再挨训完成签到 ,获得积分10
19秒前
学术乞丐完成签到,获得积分20
21秒前
咖啡博士完成签到,获得积分10
22秒前
韭黄发布了新的文献求助10
23秒前
Singularity完成签到,获得积分0
25秒前
JamesPei应助zq采纳,获得10
26秒前
所所应助韭黄采纳,获得10
30秒前
江霭完成签到,获得积分10
33秒前
鲤鱼青槐完成签到,获得积分10
42秒前
量子星尘发布了新的文献求助10
43秒前
46秒前
缥缈的冰旋完成签到,获得积分10
46秒前
52秒前
53秒前
ailemonmint完成签到 ,获得积分10
53秒前
54秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022